Izvorni znanstveni članak

https://doi.org/10.20471/acc.2019.58.01.08

Postpericardiotomy Syndrome Incidence, Diagnostic and Treatment Strategies: Experience at Two Collaborative Centers

Krešimir Gabaldo ; Cardiology Department, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia
Željko Sutlić ; Department of Cardiac Surgery, Dubrava University Hospital, Zagreb, Croatia
Domagoj Mišković ; Cardiology Department, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia
Marijana Knežević Praveček ; Cardiology Department, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia; Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Đeiti Prvulović ; Cardiology Department, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia; Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Božo Vujeva ; Cardiology Department, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia
Katica Cvitkušić Lukenda ; Cardiology Department, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia; Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Irzal Hadžibegović orcid.org/0000-0002-3768-9134 ; Department of Cardiology, Dubrava University Hospital, Zagreb, Croatia; Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia

Sažetak

Postpericardiotomy syndrome (PPS) is worsening or new formation of pericardial and/or pleural effusion mostly 1 to 6 weeks after cardiac surgery, as a result of autoimmune inflammatory reaction within pleural and pericardial space. Its incidence varies among different studies and
registries (2% to 30%), as well as according to the type of cardiac surgery performed. We conducted this retrospective analysis of PPS incidence and diagnostic and treatment strategies in patients referred
for cardiac surgery for revascularization, valvular and/or aortic surgery. We retrospectively analyzed 461 patients referred for an urgent or elective cardiac surgery procedure between 2009 and 2015. PPS diagnosis was established using well defined clinical criteria. Demographic and clinical characteristics were used in regression subanalysis among patients having undergone surgery of aortic valve
and/or ascending aorta. Within 6 weeks after cardiac surgery, 47 (10.2%) patients had PPS. The median time from the procedure to PPS diagnosis was 14 days. The incidence of PPS was 26% after aortic valve and/or aorta surgery, and 7.9% and 8.3% after coronary bypass and mitral valve surgery, respectively. Among patients subjected to aortic valve and/or aortic surgery, regression analysis showed significant association of fever, C-reactive protein (CRP) elevation between 5 and 100 mg/L, urgent procedure and postoperative antibiotic use with PPS diagnosis, whereas younger age showed nearsignificant association. All patients had complete resolution of PPS, mostly after corticosteroid therapy, with only 2 cases of recurrent PPS that successfully resolved after colchicine therapy. Pleural drainage was indicated in 15 (32%) patients, whereas only one patient required pericardial drainage. In
conclusion, PPS incidence in our retrospective analysis was similar to previous reports. Patients having undergone aortic valve and/or aortic surgery were most likely to develop PPS. The most relevant clinical criteria for diagnosis in these patients were fever, CRP elevation between 5 and 100 mg/L, and pericardial and/or pleural effusion formation or worsening 2 weeks after cardiac surgery.

Ključne riječi

Cardiac surgical procedures; Postoperative complications; Pericardial effusion; Pleural effusion; Postpericardiotomy syndrome

Hrčak ID:

220555

URI

https://hrcak.srce.hr/220555

Datum izdavanja:

1.3.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.040 *